Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KIDCARE: Infliximab vs Second IVIG for Resistant Kawasaki Disease
NCT03065244Phase 3Completed
- Sponsor
- University of California, San Diego
- Start
- Feb 2017
- Primary completion
- Aug 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab in Kawasaki disease (KD), sponsored by University of California, San Diego. Started Feb 2017; status: completed.
02
Drugs
infliximab
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on NCT03065244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03065244.